A Novel Model of Cancer
- 1 GiertzTech, Gnesta, Sweden
Abstract
This study describes a novel model of cancer. Cancer is caused, according to this model, by two toxic molecules, COF 2 (carbonyl fluoride) and CS 2 (carbon disulfide). COF 2 acts as a catalyst and produces CS 2 . CS 2 acts as a catalyst and produces COF 2 . Hence, the molecules COF 2 and CS 2 have the ability to reproduce each other, i.e. to create a chain reaction where COF 2 and CS 2 are multiplied. COF 2 and CS 2 are toxic. It is proposed that long-term cell exposure to COF 2 and CS 2 may disturb cell apoptosis and cause uncontrolled cell growth, i.e. cancer. Consequently, cancer is caused by a disease causing mechanism or agent and not by a pathogen. However, cancer can be initiated by e.g. a bacteria or virus that contain s the molecules COF 2 and CS 2 , wherein these molecules start a chain reaction producing COF 2 and CS 2 in the infected area and where the result can be cancer. The study describes why Fe 2 O 3 (iron (III) oxide) may have a therapeutic effect on cancer.
- Garcia-Viloca, M., Gao, J., Karplus, M. and Thrular, D.G. (2004) How Enzymes Work: Analysis by Modern Rate Theory and Computer Simulations. Science, 303, 186-195. https://doi.org/10.1126/science.1088172
- Applied Catalysis A: General (2001) Hoelderich Special Issue, 221, 443-457.
- Giertz, H.W. (2016) A Novel Model of the Atom. Journal of Modern Physics, 7, 413-421. https://doi.org/10.4236/jmp.2016.75042
- Mager, D.L. (2006) Bacteria and Cancer: Cause, Coincidence Or Cure? A Review. Journal of Translational Medicine, 4, 14. https://doi.org/10.1186/1479-5876-4-14
- Daniel, P., et al. (2008) Regulation of the Helicobacter pylori Cellular Receptor Decay-Accelerating Factor. Journal of Biological Chemistry, 283, Article ID 23922. https://doi.org/10.1074/jbc.M801144200
- Liao, J.B. (2006) Viruses and Human Cancer. The Yale Journal of Biology and Medicine, 79, 115-122.
- Zur Hausen, H. (1991) Viruses in Human Cancers. Science, 22, 1167-1173. https://doi.org/10.1126/science.1659743
- Volkers, N. (1999) Do Autoimmune Diseases Raise The Risk of Cancer? Journal of the National Cancer Institute, 1, 1992-1993. https://doi.org/10.1093/jnci/91.23.1992
- Rahat, M.A. and Shakya, J. (2016) Parallel Aspects of the Microenvironment in Cancer and Autoimmune Diseases. Mediators of Inflammation, 2016, Article ID 4375120. https://doi.org/10.1155/2016/4375120
- Yan, S., et al. (2005) Therapeutic Effect of Fe2O3 Nanoparticles Combined with Magnetic Fluid Hyperthermia on Cultured Liver Cells and Xenograft Liver Cancers. Journal of Nanoscience and Nanotechnology, 5, 1185-1192. https://doi.org/10.1166/jnn.2005.219
- Yan, S. (2014) Therapeutic Mechanism of Treating SMMC-7721 Liver Cancer Cells with Magnetic Fluid Hyperthermia Using Fe2O3 Nanoparticles. Brazilian Journal of Medical and Biological Research, 47, 947-959. https://doi.org/10.1590/1414-431X20143808
- Neiser, S. (2015) Physico-Chemical Properties of the New Generation IV Iron Preparations Ferumoxytol, Iron Isomaltoside 1000 and Ferric Carboxylmaltose. BioMetals, 28, 615-635. https://doi.org/10.1007/s10534-015-9845-9
- Digitale, E. (2016) Iron Nanoparticles Make Immune Cells Attack Cancer. Stanford Medicine News Center.
- Zanganeh, S., et al. (2016) Iron Oxide Nanoparticles Inhibit Tumour Growth by Inducing Pro-Inflammatory Macrophage Polarization in Tumour Tissues. Nature Nanotechnology, 11, 986-994. https://doi.org/10.1038/nnano.2016.168